MedPath
NMPA Approval

Lornoxicam for Injection

国药准字H20249829

December 25, 2024

Drug Information

注射用氯诺昔康

注射剂

8mg(每瓶实装8.6mg)

化学药品

December 25, 2024

Company Information

Applicant Company

山西省晋中市山西示范区晋中开发区汇通产业园区开发区机械园

Manufacturing Company

山西省晋中市山西示范区晋中开发区汇通产业园区开发区机械园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用氯诺昔康 - NMPA 批准文号 | MedPath